
zzso a zzso zzso appears to elicit a wide range of biological responses including zzso of protein zzso C zzso zzso one of the major elements in the signal zzso pathway, is involved in the regulation of cell growth, zzso gene zzso and tumor zzso Because of the potential for a unique mechanism of interaction with zzso a Phase I trial of zzso was performed in children with solid tumors to: zzso establish the zzso toxicity zzso and zzso dose zzso zzso establish the zzso profile in children; and zzso document any evidence of zzso zzso A zzso infusion of zzso in a PET zzso zzso zzso zzso 400, zzso ethanol, and zzso zzso zzso was administered weekly for 3 weeks to 22 children (age range, zzso zzso with zzso solid tumors zzso to conventional zzso zzso ranged from 20 to 57 zzso zzso zzso were performed in at least three patients per dose zzso The first course was used to determine the zzso and zzso Twenty-two patients on five dose levels were zzso for zzso At the 57 zzso level zzso zzso zzso 3) was observed in three zzso two of those patients also experienced zzso or eye pain, and one experienced zzso zzso occurred in all patients within zzso h after the second dose of zzso with resolution within 1 week of zzso Other observed zzso zzso 1 and 2) included zzso in liver zzso zzso fever, and zzso zzso The zzso infusion was typically well zzso Although stable disease was noted in several patients, no complete or partial responses were zzso The recommended Phase II dose of zzso administered as a zzso infusion weekly for 3 of every 4 weeks to children with solid tumors is 44 zzso zzso zzso or eye pain, as well as headache, were found to be dose zzso 

